Skip to main content
. 2022 Nov 23;15:6393–6407. doi: 10.2147/JIR.S388792

Table 1.

Basic Characteristics of Patients

Training Cohort (N=617) Validation Cohort (284)
≤60 (N=350) >60 (N=267) P value ≤60 (N=165) >60 (N=119) P value
Sex 0.090 0.459
Male 246 (70.3) 204 (76.4) 123 (74.5) 84 (70.6)
Female 104 (29.7) 63 (23.6) 42 (25.5) 35 (29.4)
BMI, median 22.84 22.95 0.230 23.31 22.64 0.038
Tumor location 0.119 0.866
Upper third 33 (9.4) 41 (15.4) 19 (11.5) 11 (9.2)
Middle third 54 (15.4) 32 (12.0) 24 (14.5) 20 (16.8)
Lower third 255 (72.9) 188 (70.4) 119 (72.1) 85 (71.4)
Total stomach 8 (2.3) 6 (2.2) 3 (1.8) 3 (2.5)
Tumor size (mm) 0.001 0.319
≤50 257 (73.4) 163 (61.0) 108 (65.5) 71 (59.7)
>50 93 (26.6) 104 (39.0) 57 (34.5) 48 (40.3)
pTNM 0.004 0.376
I 149 (42.6) 81 (30.3) 63 (38.2) 36 (30.3)
II 96 (27.4) 100 (37.5) 47 (28.5) 37 (31.1)
III 105 (30.0) 86 (32.2) 55 (33.3) 46 (38.7)
Nerve infiltration 0.057 0.499
No 187 (53.4) 122 (45.7) 76 (46.1) 50 (42.0)
Yes 163 (46.6) 145 (54.3) 89 (53.9) 69 (58.0)
Venous invasion 0.122 0.030
No 246 (70.3) 172 (64.4) 95 (57.6) 53 (44.5)
Yes 104 (29.7) 95 (35.6) 70 (42.4) 66 (55.5)
Postoperative chemotherapy <0.001 0.002
No 183 (52.3) 177 (66.3) 85 (51.5) 83 (69.7)
Yes 167 (47.7) 90 (33.7) 80 (48.5) 36 (30.3)